OpenFilings

Phio Pharmaceuticals Corp.

Form10-K

Report Period2023-12-31

Date Filed2024-04-01

Time Filed16:31:03

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K FOR 12/31/23
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE SECURITIES
CONSENT OF BDO USA, P.C.
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
INCENTIVE COMPENSATION RECOVERY POLICY
Filing on SEC Edgar